Cornercap Investment Counsel Inc Supernus Pharmaceuticals, Inc. Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$17.7 - $25.81 $364,266 - $531,169
-20,580 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$20.2 - $25.05 $330,249 - $409,542
-16,349 Reduced 44.27%
20,580 $429,000
Q2 2020

Aug 13, 2020
BUY
$17.09 - $24.89 $631,116 - $919,162
36,929 New
36,929 $877,000
Q2 2018

Aug 14, 2018
SELL
$44.1 - $59.85 $773,293 - $1.05 Million
-17,535 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$37.15 - $46.9 $651,425 - $822,391
17,535 New
17,535 $803,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.96B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email